Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,115 studies match

clinicaltrialsPublishedShowing 601–650 of 1,115 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02115373	c-Met Second-Line Hepatocellular Carcinoma	completed	Phase 1 / Phase 2	66	Merck KGaA, Darmstadt, GermanyINDUSTRY	1	Aug 24, 2022	clinicaltrials
NCT03064854	PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients	terminated	Phase 1	111	Novartis PharmaceuticalsINDUSTRY	12	Aug 15, 2022	clinicaltrials